David Iorio, DPM
Foot Surgery · Trenton, NJNPI 1366481038
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,857 of the $2,589 with a category attached, or 71.7%. Smith+Nephew accounts for 85.7% of it on its own, with 8 other manufacturers making up the rest. 2024 is the largest year on record at $2,265, more than ten times the $21 reported in 2019.
Across 29 payments — averaging $89.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Organogenesis Inc.$210
- Kerecis Limited$69
- Urgo Medical North America, LLC$23
- Paratek Pharmaceuticals, Inc.$16
- AbbVie$13
- plus $39 from 3 others
What the payments were for
- Travel & lodging$1,85772%
- Food & beverage$73228%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 11 | $2,218 |
| Organogenesis Inc. | 9 | $210 |
| Kerecis Limited | 3 | $69 |
| Urgo Medical North America, LLC | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| AbbVie | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Cashflow Solutions, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTICOAT 4" X 4"$1,123
- Allevyn Gentle Border 10 x 10cm Ctn 10$1,123
- Oasis$1,123
- PICO$1,123
- Versajet$1,123
- Grafix$899
How this compares
$2,589 in reported general payments places this provider in the 75th percentile of 59 foot surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 65 | $943 |
| Naproxen | 28 | $261 |
| Gabapentin | 27 | $224 |
| Silver Sulfadiazine | 24 | $186 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $99 |
| Pregabalin | 13 | $98 |
| Tramadol Hcl | 16 | $91 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $74 |
| Alprazolam | 13 | $16 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Trenton
- Steven GoldsteinLivingston$208K
- Paul SullivanMarlton$7K
- Timothy SorensenCape May Court House$5K
- Greg RubinsteinTeaneck$5K
- Christopher MullinAberdeen$5K
- Gary QuartelloBerkeley Hts$4K
- Graciani MartinezDover$4K
- James CancilleriNorthfield$4K
- Frank KillianToms River$3K
- Bowen YangHoboken$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.